Adenomyosis: Genomic Mechanisms and Biological Response

Withdrawn

• Conditions: Adenomyosis; Abnormal Uterine Bleeding

• Registration Number: NCT03428854
• Lead Sponsor: University of Texas Southwestern Medical Center

Brief Summary

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Detailed Description

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

Study Timeline

• Study First Submitted: 2018-02-05
• Study First Submitted QC: 2018-02-05
• Study First Posted: 2018-02-12
• Study Start: 2020-12-01
• Status Verified: 2021-01
• Last Update Submitted: 2021-01-28
• Last Update Posted: 2021-02-02
• Primary Completion: 2022-10-01
• Study Completion: 2022-10-01

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• Abnormal bleeding in the presence of Adenomyosis as demonstrated by MRI

Read More

Exclusion Criteria

• Other causes of abnormal bleeding such as fibroids, endometrial polyps, malignancy
• Presence of endometriosis

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Menstrual blood loss	12 months	Pictorial blood loss assessment chart

Secondary Outcome Measures

Name	Time	Method
Pain	12 months	Visual analog scale
Quality of Life	12 months	SF-12